Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring — Stella

Recruiting

Back to Diabetes Mellitus trials

Trial locations(2 sites)

United States

East Coast Institute for Research, LLC, Jacksonville, Florida

Excellence Medical and Research, Miami Gardens, Florida

Key details

Sponsor

Abbott Diabetes Care

Enrollment target

~800 participants

Started

October 2024

Primary completion

October 2026

Age range

18 Years and older

Last updated January 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov